Skip to content

Sonida Senior Living

US · SNDA #2860 by market cap Listed 1970
36.21 -0.91 -2.45%
Live - 5344 symbols - heartbeat 548s ago · 2026-10-08 07:05
Pre-market 36.19 -0.06%
After-hours 36.21 0.00%
Market cap
1.74B
P/B
2.02
EPS
-4.22
Reader sentiment Are you bullish or bearish on SNDA?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 2.07 Expensive vs history 68th percentile
5-year average -25.94 · #17 of 40 in Medical Care Facilities
P/E ratio -6.55 In line with history 45th percentile
5-year average -5.87 · forward -22.79
P/S ratio 3.39 Expensive vs history 89th percentile
5-year average 1.33 · forward 2.07 · #47 of 50 in Medical Care Facilities

Vs. peers Medical Care Facilities

Company Market cap P/E (TTM) P/B Div yield
Sonida Senior Living (SNDA) 1.74B -6.39 2.02 0.00%
HCA Healthcare (HCA) 95.08B 14.73 -14.32 0.68%
Tenet Healthcare (THC) 20.92B 10.04 4.49 0.00%
Encompass Health (EHC) 12.08B 19.95 4.65 0.62%
DaVita (DVA) 11.28B 14.57 -14.74 0.00%
Fresenius Medical Care (FMS) 11.01B 11.14 0.78 4.13%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value35.42 Economic moatNone UncertaintyHigh

Trading 2.2% above Morningstar's fair value estimate.

Fair value

Sonida Senior Living Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% premium over our quantitative fair value estimate of $35.42 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's lack of profitability weakens our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its gross margin of 25.6%, which falls in the bottom 40% globally. This suggests that competition is intense and profit generation could prove difficult. We believe this is a sign that shares could be expensive.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 34.6, a core component of valuation, ranks in the top 20% globally. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. This characteristic further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:05:47 · For reference only, not investment advice and not tailored to your situation.